007630.KS

Polus BioPharm Inc. [007630.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

007630.KS Stock Summary

In the News

007630.KS Financial details

Company Rating
-
Market Cap
0
Income
-2.2B
Revenue
1.31B
Book val./share
1571.86
Cash/share
1.53
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.42
Forward P/E
-
PEG
0.05
P/S
-
P/B
0.03
P/C
29.41
P/FCF
-
Quick Ratio
-
Current Ratio
0.13
Debt / Equity
1.16
LT Debt / Equity
-
-
-
EPS (TTM)
-55.16
EPS next Y
-
EPS next Q
-
EPS this Y
-68.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-38.78%
Revenue last 5Y
-26.25%
Revenue Q/Q
-
EPS Q/Q
68.98%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-7%
ROC
-0.04%
Gross Margin
10%
Oper. Margin
-36%
Profit Margin
-67%
Payout
-
Shs Outstand
44.99M
Shs Float
41.86M
-
-
-
-
Target Price
-
52W Range
30-50
52W High
-10%
52W Low
+50%
RSI
-
Rel Volume
-
Avg Volume
-
Volume
8.83M
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
-96.33%
-
-
-
-
Beta
1.03135
-
-
Volatility
0%, 0%
Prev Close
0%
Price
45
Change
-

007630.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2020-12-31

Metric History 2016-12-312017-12-312018-12-312019-12-31 2020-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.16K1.65K325.5247.93162.54
Net income per share
-1.26K-164.85-779.99-346.57-108.34
Operating cash flow per share
-259.13-741.7-486.96-73.14-234.62
Free cash flow per share
-285.92-769.68-541.38-73.2-234.62
Cash per share
1.04K202.22104.63246.745.2
Book value per share
829.671.18K1.24K1.55K1.59K
Tangible book value per share
795.451.14K1.19K1.52K1.59K
Share holders equity per share
829.671.18K1.24K1.55K1.59K
Interest debt per share
1.62K1.11K4.34K2.25K1.87K
Market cap
623.12M810.27M1.41B1.72B1.8B
Enterprise value
7.49B17.55B112.93B72.91B75.08B
P/E ratio
-0.04-0.27-0.06-0.13-0.42
Price to sales ratio
0.020.030.140.180.28
POCF ratio
-0.17-0.06-0.09-0.62-0.19
PFCF ratio
-0.16-0.06-0.08-0.61-0.19
P/B Ratio
0.050.040.040.030.03
PTB ratio
0.050.040.040.030.03
EV to sales
0.250.5911.117.6911.52
Enterprise value over EBITDA
-0.59-11.08-52.18-12.02-33.45
EV to operating cash flow
-2.09-1.31-7.43-26.05-7.98
EV to free cash flow
-1.89-1.27-6.68-26.03-7.98
Earnings yield
-28-3.66-17.33-7.7-2.41
Free cash flow yield
-6.35-17.1-12.03-1.63-5.21
Debt to equity
1.850.892.941.351.16
Debt to assets
0.360.350.690.530.5
Net debt to EBITDA
-0.54-10.57-51.53-11.73-32.65
Current ratio
0.510.280.050.130.13
Interest coverage
-4.42-4.94-0.43-0.66-1.43
Income quality
0.214.50.620.212.17
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.020.010.090.040.02
Research and developement to revenue
0.020.020.0300
Intangibles to total assets
0.010.010.010.010
Capex to operating cash flow
0.10.040.1100
Capex to revenue
-0.01-0.02-0.1700
Capex to depreciation
-0.39-1.41-2.6700
Stock based compensation to revenue
000.0800
Graham number
4.85K2.1K4.67K3.48K1.97K
ROIC
-0.21-0.13-0.08-0.02-0.02
Return on tangible assets
-0.3-0.05-0.15-0.09-0.03
Graham Net
-2.4K-1.65K-3.91K-2.15K-2.1K
Working capital
-21.6B-21.07B-114.98B-77.17B-71.48B
Tangible asset value
11.01B20.51B37.14B58.15B63.57B
Net current asset value
-25.94B-25.43B-119.51B-80.32B-74.08B
Invested capital
1.850.892.941.351.16
Average receivables
00000
Average payables
15.76B12.56B3.54B75.45M41.76M
Average inventory
2.99B623.27M482.06M351.35M88.62M
Days sales outstanding
00000
Days payables outstanding
235.2289.972.683.510.03
Days of inventory on hand
11.025.1122.385.762.52
Receivables turnover
00000
Payables turnover
1.554.06136.21104.0614.17K
Inventory turnover
33.1371.4816.3163.32144.62
ROE
-1.52-0.14-0.63-0.22-0.07
Capex per share
-26.79-27.97-54.41-0.060

Quarterly Fundamentals Overview

Last date of statement is 2021-06-30 for Q2

Metric History 2020-06-302020-09-302020-12-312021-03-31 2021-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
37.9726.845.960.490
Net income per share
-27.4-4.24-36.61-5.32-8.99
Operating cash flow per share
-38.22-196.51-20.68-4.57-4.51
Free cash flow per share
-38.22-196.51-20.68-4.57-4.51
Cash per share
241.7547.865.30.661.53
Book value per share
1.45K1.45K1.62K1.41K1.57K
Tangible book value per share
1.42K1.42K1.62K1.41K1.57K
Share holders equity per share
1.45K1.45K1.62K1.41K1.57K
Interest debt per share
2.08K2.08K1.87K1.62K1.82K
Market cap
1.77B1.77B1.77B2.02B1.8B
Enterprise value
75.19B83.12B75.05B75.05B74.68B
P/E ratio
-0.41-2.66-0.31-2.11-1.25
Price to sales ratio
1.191.687.5591.330
POCF ratio
-1.18-0.23-2.18-9.85-9.97
PFCF ratio
-1.18-0.23-2.18-9.85-9.97
P/B Ratio
0.030.030.030.030.03
PTB ratio
0.030.030.030.030.03
EV to sales
50.478.83320.363.39K0
Enterprise value over EBITDA
-70.72-462.2-64.77-365.28-207.12
EV to operating cash flow
-50.06-10.77-92.38-365.1-412.69
EV to free cash flow
-50.06-10.77-92.38-365.1-412.69
Earnings yield
-0.61-0.09-0.81-0.12-0.2
Free cash flow yield
-0.85-4.37-0.46-0.1-0.1
Debt to equity
1.431.441.161.151.16
Debt to assets
0.550.550.50.490.49
Net debt to EBITDA
-69.06-452.37-63.24-355.43-202.12
Current ratio
0.120.120.130.130.13
Interest coverage
00234.5700
Income quality
1.446.390.560.860.5
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.540.4-0.30.580
Research and developement to revenue
00000
Intangibles to total assets
0.010.01000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
946.19371.371.15K410.65563.98
ROIC
-0.010000
Return on tangible assets
-0.010-0.0100
Graham Net
-2.11K-2.31K-2.15K-1.88K-2.11K
Working capital
-79.61B-79.45B-71.48B-71.68B-71.83B
Tangible asset value
55.88B55.97B63.57B63.33B62.97B
Net current asset value
-82.21B-82.05B-74.08B-74.27B-74.42B
Invested capital
1.431.441.161.151.16
Average receivables
00000
Average payables
428.5K416K415.5K207.5K0
Average inventory
141.36M68.56M54.06M21.36M5.52M
Days sales outstanding
00000
Days payables outstanding
0.020.050.1700
Days of inventory on hand
3.927.9317.144.38-116.99
Receivables turnover
00000
Payables turnover
3.84K1.84K514.3400
Inventory turnover
22.9611.355.2520.54-0.77
ROE
-0.020-0.020-0.01
Capex per share
00000

007630.KS Frequently Asked Questions

What is Polus BioPharm Inc. stock symbol ?

Polus BioPharm Inc. is a US stock and trading under the symbol 007630.KS

What is Polus BioPharm Inc. stock quote today ?

Polus BioPharm Inc. stock price is $45 today.

Is Polus BioPharm Inc. stock public?

Yes, Polus BioPharm Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Same Price Range
Similar Market Cap